Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EGCG in Healthy and Obese Subjects
NCT00434499Phase 2Withdrawn
- Sponsor
- University of Maryland, Baltimore
- Start
- Feb 2007
- Primary completion
- Dec 2015
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of epigallocatechin gallate in insulin resistance (IR), hypertension (HTN), sponsored by University of Maryland, Baltimore. Planned start Feb 2007; status: withdrawn.
02
Drugs
epigallocatechin gallate
03
Conditions
insulin resistance (IR)hypertension (HTN)
Beyond the preview
Go deeper on NCT00434499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00434499.